Suppr超能文献

碳水化合物结合蛋白35。二、重组多肽与糖类相互作用的分析。

Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides.

作者信息

Knibbs R N, Agrwal N, Wang J L, Goldstein I J

机构信息

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor 48109-0606.

出版信息

J Biol Chem. 1993 Jul 15;268(20):14940-7.

PMID:8325871
Abstract

The carbohydrate binding specificity of recombinant carbohydrate-binding protein 35 (rCBP35) has been investigated by quantitative precipitation using a series of glycoproteins and carbohydrate-protein conjugates and by inhibition of precipitation using well defined carbohydrate haptens. Synthetic glycoconjugates and glycoproteins containing terminal nonreducing galactosyl units in beta-linkage were capable of forming a precipitate with rCBP35. If the glycoprotein or glycoconjugate contained terminal Neu5Ac, or galactose in alpha-linkage, precipitate formation was not observed. We also found that murine laminin, which contains polylactosamine structures, reacted more strongly than did bovine fetuin. Using carbohydrate-bovine serum albumin (BSA) glycoconjugates, we found that the tetrasaccharide Gal beta 1, 4GlcNAc beta 1, 3Gal beta 1,4-GlcNAc-BSA reacted more strongly than the disaccharide Gal beta 1, 4GlcNAc-BSA conjugate, suggesting that the binding site accommodates carbohydrate ligands greater in size than a disaccharide. Equilibrium dialysis experiments using [3H]lactose showed that rCBP35 binds 1 mol (n = 0.84) of lactose/30,000 g atoms of protein, with an affinity constant of 2.07 x 10(4) M-1. The binding site on the polypeptide appears to contain four subsites that recognize the sequence Gal beta 1,4GlcNAc beta 1, Gal beta 1,X-. All disaccharides tested that contain a nonreducing beta-galactosyl unit behaved as inhibitors of precipitation at approximately the same concentration, suggesting that the reducing position of the tetrasaccharide does not play an important role in the specific binding to the fourth subsite. The reducing sugar may serve to hold the saccharide in a tunnel like binding pocket since methyl-beta-D-galactoside itself is an extremely poor inhibitor.

摘要

通过使用一系列糖蛋白和碳水化合物 - 蛋白质缀合物进行定量沉淀,以及使用明确的碳水化合物半抗原抑制沉淀,研究了重组碳水化合物结合蛋白35(rCBP35)的碳水化合物结合特异性。含有β-连接的末端非还原半乳糖基单元的合成糖缀合物和糖蛋白能够与rCBP35形成沉淀。如果糖蛋白或糖缀合物含有末端Neu5Ac或α-连接的半乳糖,则未观察到沉淀形成。我们还发现,含有聚乳糖胺结构的小鼠层粘连蛋白比牛胎球蛋白反应更强。使用碳水化合物 - 牛血清白蛋白(BSA)糖缀合物,我们发现四糖Galβ1,4GlcNAcβ1,3Galβ1,4 - GlcNAc - BSA比二糖Galβ1,4GlcNAc - BSA缀合物反应更强,这表明结合位点容纳的碳水化合物配体大小大于二糖。使用[3H]乳糖的平衡透析实验表明,rCBP35结合1摩尔(n = 0.84)乳糖/30,000克原子蛋白质,亲和常数为2.07×10(4) M-1。多肽上的结合位点似乎包含四个亚位点,可识别序列Galβ1,4GlcNAcβ1,Galβ1,X - 。所有测试的含有非还原β-半乳糖基单元的二糖在大约相同浓度下均表现为沉淀抑制剂,这表明四糖的还原位置在与第四亚位点的特异性结合中不起重要作用。还原糖可能用于将糖类保持在类似隧道的结合口袋中,因为甲基 - β-D - 半乳糖苷本身是一种极差的抑制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验